CIBC Private Wealth Group’s Novavax NVAX Stock Holding History

CIBC Private Wealth Group’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$15.5K	Buy	2,308 +995	+76%	+$7.5K	﹤0.01%	2261
2025 Q3	$11.4K	Hold	1,313	–	–	﹤0.01%	2343
2025 Q2	$8.27K	Sell	1,313 -995	-43%	-$6.59K	﹤0.01%	2325
2025 Q1	$14.6K	Hold	2,308	–	–	﹤0.01%	2105
2024 Q4	$22.2K	Hold	2,308	–	–	﹤0.01%	2013
2024 Q3	$29.1K	Hold	2,308	–	–	﹤0.01%	1993
2024 Q2	$27.8K	Buy	2,308 +2,000	+649%	+$20.1K	﹤0.01%	1907
2024 Q1	$1.43K	Buy	+308	New	+$1.43K	﹤0.01%	2811
2019 Q1	–	Sell	-3,500	Closed	-$129K	–	947
2018 Q4	$129K	Hold	3,500	–	–	﹤0.01%	845
2018 Q3	$132K	Buy	+3,500	New	+$98.6K	﹤0.01%	937

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Private Wealth Group's NVAX Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Novavax (NVAX) stake by 76% in Q4 2025, buying an estimated $7.5K and bringing the position to 2,308 shares worth $15.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2261.

CIBC Private Wealth Group first reported a position in NVAX in Q3 2018 and has held it in 10 quarters since. The position peaked at $132K in Q3 2018. 235 funds tracked by Wall St. Rank hold NVAX as of Q4 2025.

CIBC Private Wealth Group held 2,308 shares of Novavax worth $15.5K as of Q4 2025.
CIBC Private Wealth Group bought 995 Novavax shares in Q4 2025, an estimated $7.5K.
Novavax made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2261 holding.
CIBC Private Wealth Group first reported a position in Novavax in Q3 2018 and has held it in 10 quarters since.
CIBC Private Wealth Group's Novavax position peaked at $132K in Q3 2018.
235 funds tracked by Wall St. Rank held Novavax as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.